⌘K
Loading ticker…
Sagimet Biosciences Inc. Series A Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a 3-month relative strength percentile of 85 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.1%, relative volume 9.18×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 85, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
SGMT is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $4M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $4M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SGMT Jan avg: 22.82% median: -2.22% win: 33% σ: 45.12% n: 3 2023-07-17 → 2026-05-29 | SGMT Feb avg: -16.73% median: -15.57% win: 33% σ: 18.05% n: 3 2023-07-17 → 2026-05-29 | SGMT Mar avg: -10.78% median: -11.58% win: 0% σ: 2.00% n: 3 2023-07-17 → 2026-05-29 | SGMT Apr avg: 10.49% median: 5.83% win: 67% σ: 41.06% n: 3 2023-07-17 → 2026-05-29 | SGMT May avg: 10.12% median: 2.90% win: 67% σ: 23.78% n: 3 2023-07-17 → 2026-05-29 | SGMT Jun avg: 39.41% median: 39.41% win: 50% σ: 106.41% n: 2 2023-07-17 → 2026-05-29 (current) | SGMT Jul avg: 4.10% median: 0.00% win: 67% σ: 8.66% n: 3 2023-07-17 → 2026-05-29 | SGMT Aug avg: -15.39% median: -13.58% win: 0% σ: 8.12% n: 3 2023-07-17 → 2026-05-29 | SGMT Sep avg: -15.29% median: -10.06% win: 0% σ: 10.30% n: 3 2023-07-17 → 2026-05-29 | SGMT Oct avg: 17.24% median: 24.20% win: 67% σ: 72.42% n: 3 2023-07-17 → 2026-05-29 | SGMT Nov avg: -0.13% median: 4.37% win: 67% σ: 13.45% n: 3 2023-07-17 → 2026-05-29 | SGMT Dec avg: 0.99% median: -18.01% win: 33% σ: 35.45% n: 3 2023-07-17 → 2026-05-29 |